Evidence map›Paper›PMID 36289724›Full record

ArticleBiomedicines2022

The Role of [

Luca Urso, Giovanni Christian Rocca, Francesca Borgia, Federica Lancia, Antonio Malorgio, Mauro Gagliano, Mauro Zanetto, Licia Uccelli, Corrado Cittanti, Carmelo Ippolito and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luca UrsoDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy.ORCID 0000-0002-3007-3898
Giovanni Christian RoccaUrology Unit, Surgical Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Francesca BorgiaDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy.ORCID 0000-0002-9753-9699
Federica LanciaOncology Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.
Antonio MalorgioRadiotherapy Unit, University Hospital of Ferrara, 44124 Ferrara, Italy.
Mauro GaglianoHospital Radiology, University Hospital of Ferrara, 44124 Ferrara, Italy.
Mauro ZanettoDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy.
Licia UccelliDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy.ORCID 0000-0002-1490-0718
Corrado CittantiDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy.ORCID 0000-0002-5117-804X
Carmelo IppolitoOncology Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-5331-2687
Laura EvangelistaDepartment of Medicine DIMED, University of Padua, 35128 Padua, Italy.ORCID 0000-0002-5955-9488
Mirco BartolomeiNuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44124 Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initial staging of prostate cancer (PCa) is usually performed with conventional imaging (CI), involving computed tomography (CT) and bone scanning (BS). The aim of this study was to analyze the role of [

Indexed as

[18F]F-choline PET/CTconventional imagingoutcomeprostate cancer

Identifiers

PMID36289724
PMCPMC9598779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.